Predicted to enable RNA binding activity and sequence-specific double-stranded DNA binding activity. Predicted to be involved in regulation of alternative mRNA splicing, via spliceosome. Predicted to be active in cytoplasm and nucleoplasm. Orthologous to human MBNL2 (muscleblind like splicing regulator 2). [provided by Alliance of Genome Resources, Apr 2022]